MFDS Holds 'Pharmaceutical Clinical Trial Policy Briefing'

[Asia Economy Reporter Lee Gwan-ju] The Ministry of Food and Drug Safety announced on the 23rd that it will hold the '2023 Pharmaceutical Clinical Trial Policy Briefing' for domestic clinical trial stakeholders at the aT Center in Seocho-gu, Seoul.

At this briefing, the following will be covered: ▲2023 pharmaceutical clinical trial policy directions ▲recent amendments to laws related to clinical trials ▲basic plan for clinical trial status survey ▲review procedures of the Central Institutional Review Board (Central IRB).

The briefing materials will be made available later on the Ministry of Food and Drug Safety website. The Ministry stated, "This policy briefing is expected to enhance the understanding of clinical trial policy directions among pharmaceutical companies and researchers, assist in preparing materials necessary for clinical trial plan approval, and help ensure safety management during clinical trial execution." They added, "We will continue to create opportunities for communication with the industry."